TAMPERE, Finland, April 24, 2026 — Bioretec Ltd Company announcement 24 April 2026 at […]
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
NEW YORK, April 24, 2026 — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a […]
Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
CRANFORD, N.J., April 24, 2026 — Citius Pharmaceuticals Inc. (Nasdaq: CTXR) (“Citius Pharma” or […]
Target Hospitality Announces Closing of Secondary Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
THE WOODLANDS, Texas, April 23, 2026 — Target Hospitality Corp. (“Target Hospitality” or the […]
Aircastle Announces Pricing of $650 Million Aggregate Principal Amount of 5.000% Senior Notes Due 2031
STAMFORD, Conn., April 23, 2026 — Aircastle Limited (“Aircastle”) announced today that it and […]
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN FRANCISCO, April 23, 2026 — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company […]
Lakewood-Amedex Biotherapeutics Announces Direct Listing on Nasdaq; Shares Trading Under the Symbol “LABT”
SARASOTA, Fla., April 23, 2026 — Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT), a clinical-stage biotechnology […]
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
NEW YORK, April 23, 2026 — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a […]
Danaher Announces Pricing of Euro-Denominated Senior Notes Offering
WASHINGTON, April 22, 2026 — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that it […]